Compound information
- Natural Products
- ZC2196913
- Molecular Formula
- C19H21NO4
- Molecular Weight
- 327.147058152 g/mol
- Structure
-
- IUPAC Name
- (3S)-3-(benzyloxycarbonylamino)-3-(4-ethylphenyl)propanoic acid
- InChI
- InChI=1S/C19H21NO4/c1-2-14-8-10-16(11-9-14)17(12-18(21)22)20-19(23)24-13-15-6-4-3-5-7-15/h3-11,17H,2,12-13H2,1H3,(H,20,23)(H,21,22)/t17-/m0/s1
- InChI Key
- MKMJKHUWUFEEST-KRWDZBQOSA-N
- SMILES
- CCc1ccc([C@H](CC(=O)O)NC(=O)OCc2ccccc2)cc1
- Source
- ZINC000002511975
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 24 | Ring Count | 2 |
Heteroatom Count | 5 | Rotatable Bond Count | 7 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 75.63 Å2 | LogP | 3.522 |
LogS | -4.106 | LogD | 2.765 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.001 | Pgp substrate | 0.004 |
HIA | 0.966 | F20 % | 0.993 |
F30 % | 0.45 | Caco-2 | -5.377 |
MDCK | -4.766 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.124 | PPB | 99.162 |
VD | 0.337 | Fu | 1.577 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.049 | CYP1A2 substrate | 0.692 |
CYP2A6 substrate | 0.261 | CYP2B6 substrate | 0.414 |
CYP2C19 inhibitor | 0.208 | CYP2C19 substrate | 0.718 |
CYP2C8 substrate | 0.827 | CYP2C9 inhibitor | 0.506 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.084 |
CYP2D6 substrate | 0.42 | CYP2E1 substrate | 0.159 |
CYP3A4 inhibitor | 0.036 | CYP3A4 substrate | 0.991 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.739 | CL | 2.275 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.002 | Hepatotoxicity | 0.991 |
Mutagenicity | 0.035 | Rat Oral Acute Toxicity | 0.117 |
FDAMDD | 0.55 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.047 | Eye Corrosion | 0.004 |
Eye Irritation | 0.017 | Respiratory Toxicity | 0.004 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.176 | IGC50 | 2.538 |
LC50FM | 3.593 | LC50DM | 4.915 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.247 | NR-AR-LBD | 0.229 |
NR-AhR | 0.007 | NR-Aromatase | 0.043 |
NR-ER | 0.308 | NR-ER-LBD | 0.329 |
NR-PPAR-gamma | 0.676 | SR-ARE | 0.049 |
SR-ATAD5 | 0.362 | SR-HSE | 0.092 |
SR-MMP | 0.011 | SR-p53 | 0.019 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.